I build systems to measure

and reprogram human aging.

20+

PATENTS

Named inventor

80+

PUBLICATIONS

Including Cell, Nature, PNAS



What I Build

Scientific Discovery

Advancing how human aging is measured and understood.

Translational Platforms

Turning biological insight into deployable technologies.

Company Creation

Founding ventures that bring frontier science into real-world medicine.

David Furman

I build scientific systems that transform
discovery into real-world impact.

Founded to bring Inflammatory Age technologies out of the laboratory and into everyday health
Founded to make human aging measurable and actionable through science. Built on microgravity technologies originally developed for spaceflight research
Founded to scale high-dimensional clinical testing through ultra-low sample volume diagnostics

Additional Cover

C Gerónimo‐Olvera, SM Scheeler, CG Aguirre, G Vega‐Hormazabal, ... Aging Cell 25 (5), e70549, 2026
2026
Speaker Sep. 14, 2026

Longevity Investors Conference

Gstaad, Switzerland

Speaker Ago. 17, 2026

3rd International Medical Symposium

Hong Kong, China

Speaker Mar. 14, 2026

What Works for Me? Measuring Aging Across the Lifespan

San Francisco, CA

Panelist and Speaker Mar. 12, 2026

Intrinsic Capacity and Its Rate of Decline: Blood Biomarkers and Prediction of Long-term Health

Washington, DC

Speaker Feb. 5, 2026

Amway Scientific Advisory Board

Tokyo, Japan

Keynote Speaker Ene. 31, 2026

The Power of Aging Clocks

New York City, New York

Speaker Ene. 21, 2026

Speaker, Reversing Age Board Meeting

Paris, France

Longevity Technology
The Scientist
M IJ
Futurity
Nature
Longevity Technology
JMIR Publications
bioRxiv
YourTango
MarketWatch
Next Avenue
AARP
Big Think
Longevity Technology
The Scientist
M IJ
Futurity
Nature
Longevity Technology
JMIR Publications
bioRxiv
YourTango
MarketWatch
Next Avenue
AARP
Big Think
Chicago Tribune
InStyle
Medical News Today
Elite Daily
Bravo TV
TIME
Stanford Medicine
Medscape
The Independent
Gizmodo
NBC News
HealthDay
Chicago Tribune
InStyle
Medical News Today
Elite Daily
Bravo TV
TIME
Stanford Medicine
Medscape
The Independent
Gizmodo
NBC News
HealthDay

He has this unusual ability to sit at the intersection of immunology, AI, and medicine and actually create something useful out of it. A lot of people work in those areas, but very few connect them in a way that produces tools applicable to real human health.

Vadim GladyshevProfessor of medicine at Brigham and Women's Hospital, Harvard Medical School

What I find most impressive is David's end-to-end approach—from uncovering biological signals using AI and ML, to developing them into longevity biomarkers, and finally into real-world systems that people can actually use.

Michael SnyderStanford W. Ascherman Professor of Genetics, Stanford University

He's done terrific work on aging biomarkers and human cohort-based aging clocks that are utilized in real world settings.

George ChurchProfessor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology

Geroscience flourishes because aging drives age-related disease, and targeting this biology is the revolution that transforms our health. David Furman has shown that aging isn’t passive or genetically fixed but continuously shaped by environment, behavior, and immune dynamics — reshaping how we approach prevention and longevity.

Nir BarzilaiProfessor and Director, Einstein Institute for Aging Research at Albert Einstein College of Medicine

David’s work stands out because he treats the immune system as a high-dimensional sensor of human health, and then uses AI to decode those signals into biomarkers that predict functional decline and disease risk.

Evelyne BischofPresident, Healthy Longevity Medicine Society

He approaches intrinsic capacity and functional decline as a measurable output of underlying immune, epigenetic and molecular networks, which makes it far more actionable.

Heike A. Bischoff-FerrariProfessor of Geriatrics, University of Basel, Switzerland, Director, Swiss Campus for Healthy Longevity

Dr. Furman builds innovative methods to connect space biology to human health and longevity, using immune system responses in microgravity to uncover novel biological mechanisms and dynamics.

Chris MasonWorldQuant Professor of Genomics, Physiology, & Biophysics, Weill Cornell Medicine

David's work stands out for its ability to integrate multi-modal human data to identify immune aging biomarkers with real clinical utility — bridging the gap between computational discovery and actionable insights for healthy longevity.

Duygu UcarProfessor, Jackson Laboratory

David’s approach to predicting long-term human health outcomes is impressive and his inflammatory clocks are transformative because they quantify a core biological process that directly impacts clinical outcomes.

Jamie JusticeEVP at XPRIZE Foundation, Adjunct Professor Center on Healthy Aging Wake Forest University School of Medicine (WFUSM)

David brings exceptional expertise in molecular and deep multi-omics profiling, combined with advanced AI, to uncover and understand the biological drivers of aging; he is a rigorous scientist with a clear and compelling vision.

Eric VerdinPresident and chief executive officer of the Buck Institute for Research on Aging

To advance discovery in healthy aging, we need expertise in the biology of aging, bioinformatics, AI, and the ability to understand clinical applications. Very few people can bring all of these competencies together. David Furman is one of them.

Bruno VellasChair of the Gérontopôle & Department of Geriatric Internal Medicine at the Toulouse University Hospital, France

He is among the few scientists who use AI not just for prediction, but to uncover the biological structure of aging and identify actionable targets within it.

Elizabeth BohamFunctional Medicine Physician Medical Director at The UltraWellness Center

What makes David exceptional is that he has built an end-to-end framework, from biomarker data acquisition to AI-driven modeling to intervention discovery, that is both scientifically rigorous and practically deployable, with clear applicability in longevity clinics where it can be used to translate complex biological data into personalized, actionable interventions that improve patient outcomes and optimize long-term health.

Joanna BenszFounder and CEO, Longevity Center Europe Founder and Co-Chair of the International Institute of Longevity

David’s impressive contribution is not just new biomarkers, but a novel system using muti-omics and AI for discovering them, validating them, and translating them into interventions to extend healthspan and prevent disease.

Joy KongTriple board-certified UCLA physician, global leader in stem cell therapy and anti-aging innovation.

David’s research connects immune system dynamics, biomarker discovery, and intervention design into a single pipeline applicable to real world problems, which is very rare in the field.

Max MarchioneFounder of Superpower

Schedule your appointment whenever it’s convenient for you through the link below.